Papers associated with cranial nerve (and grin2a)

Limit to papers also referencing gene:
Show all cranial nerve papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors., Yuan H., J Biol Chem. May 8, 2009; 284 (19): 12862-73.
	Pharmacological characterization of recombinant NR1/NR2A NMDA receptors with truncated and deleted carboxy termini expressed in Xenopus laevis oocytes., Puddifoot CA., Br J Pharmacol. February 1, 2009; 156 (3): 509-18.
	Binding of spermine and ifenprodil to a purified, soluble regulatory domain of the N-methyl-D-aspartate receptor., Han X., J Neurochem. December 1, 2008; 107 (6): 1566-77.
	Mutations within the selectivity filter of the NMDA receptor-channel influence voltage dependent block by 5-hydroxytryptamine., Kloda A., Br J Pharmacol. September 1, 2006; 149 (2): 163-9.
	Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission., Frizelle PA., Mol Pharmacol. September 1, 2006; 70 (3): 1022-32.
	Nickel differentially affects NMDA receptor channels in developing cultured rat neurons., Gavazzo P., Dev Biol. March 17, 2006; 1078 (1): 71-9.
	NMDA receptors as targets of heavy metal interaction and toxicity., Marchetti C., Neurotox Res. November 1, 2005; 8 (3-4): 245-58.
	Synthesis, binding affinity at glutamic acid receptors, neuroprotective effects, and molecular modeling investigation of novel dihydroisoxazole amino acids., Conti P., J Med Chem. October 6, 2005; 48 (20): 6315-25.
	Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D-aspartate-gated channels., Chen HS., J Pharmacol Exp Ther. September 1, 2005; 314 (3): 961-71.
	Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling., Chen PE., Mol Pharmacol. May 1, 2005; 67 (5): 1470-84.
	Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists., Morley RM., J Med Chem. April 7, 2005; 48 (7): 2627-37.
	The effect of competitive antagonist chain length on NMDA receptor subunit selectivity., Feng B., Neuropharmacology. March 1, 2005; 48 (3): 354-9.
	The micromolar zinc-binding domain on the NMDA receptor subunit NR2B., Rachline J., J Neurosci. January 12, 2005; 25 (2): 308-17.
	Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape 'superslow' afterburst EPSC in rat hippocampus., Lozovaya NA., J Physiol. July 15, 2004; 558 (Pt 2): 451-63.
	Differential modulation of NR1-NR2A and NR1-NR2B subtypes of NMDA receptor by PDZ domain-containing proteins., Iwamoto T., J Neurochem. April 1, 2004; 89 (1): 100-8.
	Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid., Feng B., Br J Pharmacol. February 1, 2004; 141 (3): 508-16.
	Clozapine inhibits isolated N-methyl-D-aspartate receptors expressed in xenopus oocytes in a subunit specific manner., Levine JB., Neurosci Lett. August 7, 2003; 346 (3): 125-8.

???pagination.result.page??? 1